Covered recipient · General Payments record
MUHAMMAD NAEEM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,785.98
- Reported across 191 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.84 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $163.63 | 9 |
| PFIZER INC. | $60.93 | 3 |
| Lilly USA, LLC | $47.38 | 3 |
| Amneal Pharmaceuticals LLC | $21.97 | 1 |
| Lundbeck LLC | $16.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.96 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092277 | CMS |
| ABBVIE INC. | $23.97 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092279 | CMS |
| ABBVIE INC. | $22.61 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092281 | CMS |
| ABBVIE INC. | $17.24 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092283 | CMS |
| ABBVIE INC. | $28.25 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092285 | CMS |
| ABBVIE INC. | $31.13 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092287 | CMS |
| ABBVIE INC. | $3.90 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092289 | CMS |
| ABBVIE INC. | $10.97 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092291 | CMS |
| ABBVIE INC. | $7.60 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105092293 | CMS |
| Amneal Pharmaceuticals LLC | $21.97 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139196094 | CMS |
| Lilly USA, LLC | $16.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135227286 | CMS |
| Lilly USA, LLC | $15.68 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135255229 | CMS |
| Lilly USA, LLC | $14.86 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135174969 | CMS |
| Lundbeck LLC | $16.93 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145949226 | CMS |
| PFIZER INC. | $19.10 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131243767 | CMS |
| PFIZER INC. | $19.97 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131454184 | CMS |
| PFIZER INC. | $21.86 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131869972 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.